PetMed Express (NASDAQ:PETS) Shares Cross Above 200-Day Moving Average – Here’s Why

PetMed Express, Inc. (NASDAQ:PETS) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.25 and traded as high as $5.00. PetMed Express shares last traded at $4.99, with a volume of 213,574 shares trading hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

PetMed Express Price Performance

The stock has a 50 day simple moving average of $5.08 and a 200-day simple moving average of $4.25. The firm has a market cap of $103.09 million, a PE ratio of -83.17 and a beta of 0.69.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million during the quarter, compared to analyst estimates of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. As a group, equities analysts predict that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

Insider Buying and Selling at PetMed Express

In related news, Director Leslie C.G. Campbell bought 15,000 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was acquired at an average price of $5.38 per share, with a total value of $80,700.00. Following the transaction, the director now owns 70,000 shares in the company, valued at approximately $376,600. This trade represents a 27.27 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. R Squared Ltd purchased a new stake in PetMed Express in the fourth quarter worth about $31,000. Point72 DIFC Ltd bought a new position in shares of PetMed Express during the 2nd quarter valued at about $34,000. Marshall Wace LLP purchased a new position in PetMed Express during the 2nd quarter valued at approximately $46,000. Independent Advisor Alliance bought a new stake in PetMed Express in the third quarter worth $106,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of PetMed Express during the 2nd quarter valued at about $135,000. 73.33% of the stock is owned by hedge funds and other institutional investors.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.